These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 8059)

  • 21. Effects of buprenorphine on motility in morphine post-dependent rats.
    Bartoletti M; Gaiardi M; Gubellini C
    Pharmacol Res; 1999 Oct; 40(4):327-32. PubMed ID: 10527644
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Uridine decreases morphine-induced behavioral sensitization by decreasing dorsal striatal dopamine release possibly via agonistic effects at GABAA receptors.
    Liu P; Wu C; Song W; Yu L; Yang X; Xiang R; Wang F; Yang J
    Eur Neuropsychopharmacol; 2014 Sep; 24(9):1557-66. PubMed ID: 25088943
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alterations of dopaminergic neurotransmission after chronic morphine treatment: pre- and postjunctional studies in striatal tissue.
    Bosse A; Kuschinsky K
    Naunyn Schmiedebergs Arch Pharmacol; 1976 Jul; 294(1):17-22. PubMed ID: 187960
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dopamine and serotonin metabolism associated with morphine reward and its inhibition with buspirone: A study in the rat striatum.
    Haleem DJ; Nawaz S; Salman T
    Pharmacol Biochem Behav; 2018 Jul; 170():71-78. PubMed ID: 29782941
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stimulation and inhibition of serotoninergic mechanisms in rat brain: alterations of morphine effects on striatal dopamine metabolism and on motility.
    Groppe G; Kuschinsky K
    Neuropharmacology; 1975 Sep; 14(9):659-64. PubMed ID: 1080841
    [No Abstract]   [Full Text] [Related]  

  • 26. Chronic morphine treatment induces over-expression of HSP70 in mice striatum related with abnormal ubiquitin-proteasome degradation.
    Yang HY; Pu XP; Liu Y
    Drug Alcohol Depend; 2014 Jun; 139():53-9. PubMed ID: 24685564
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Narcotic dependence, narcotic action and dopamine receptors.
    Lal H
    Life Sci; 1975 Aug; 17(4):483-95. PubMed ID: 171531
    [No Abstract]   [Full Text] [Related]  

  • 28. Effects of morphine on striatal dopamine metabolism: possible mechanism of its opposite effect on locomotor activity in rats and mice.
    Kuschinsky K; Hornykiewicz O
    Eur J Pharmacol; 1974 Apr; 26(1):41-50. PubMed ID: 4598755
    [No Abstract]   [Full Text] [Related]  

  • 29. Brain-stimulation reward, morphine-induced oral stereotypy, and sensitization: implications for abuse.
    Kornetsky C
    Neurosci Biobehav Rev; 2004 Jan; 27(8):777-86. PubMed ID: 15019427
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Motility, rigidity and turnover of dopamine in the striatum after administration of morphine to rats: a re-evaluation of their mechanisms.
    Genç E; Havemann U; Tzoneva-Tyutyulkova N; Kuschinsky K
    Neuropharmacology; 1983 Apr; 22(4):471-6. PubMed ID: 6304566
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Opiate-induced changes in brain adenosine levels and narcotic drug responses.
    Wu M; Sahbaie P; Zheng M; Lobato R; Boison D; Clark JD; Peltz G
    Neuroscience; 2013 Jan; 228():235-42. PubMed ID: 23098802
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Revisiting tolerance from the endogenous morphine perspective.
    Stefano GB; Kream RM; Esch T
    Med Sci Monit; 2009 Sep; 15(9):RA189-98. PubMed ID: 19721410
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dopaminergic involvement in the mechanism of action of pentazocine.
    Hernández LL; Appel JB
    Behav Neural Biol; 1979 Aug; 26(4):384-400. PubMed ID: 227353
    [No Abstract]   [Full Text] [Related]  

  • 34. Up-regulation of adenosine transporter-binding sites in striatum and hypothalamus of opiate tolerant mice.
    Kaplan GB; Leite-Morris KA
    Brain Res; 1997 Jul; 763(2):215-20. PubMed ID: 9296562
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of cerebral dopamine and noradrenaline in the morphine-induced locomotor sensitisation in mice.
    Airio J; Ahtee L
    Pharmacol Biochem Behav; 1997 Oct; 58(2):379-86. PubMed ID: 9300596
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Endogenous opioid-dopamine neurotransmission underlie negative CBV fMRI signals.
    Shih YY; Chiang YC; Shyu BC; Jaw FS; Duong TQ; Chang C
    Exp Neurol; 2012 Apr; 234(2):382-8. PubMed ID: 22245158
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential action of dopamine agonists on brain self-stimulation behaviour in rats.
    Wauquier A
    Arch Int Pharmacodyn Ther; 1978 Dec; 236(2):325-8. PubMed ID: 747483
    [No Abstract]   [Full Text] [Related]  

  • 38. Effects of various opiates including specific delta and mu agonists on dopamine release from nigrostriatal dopaminergic neurons in vitro in the rat and in vivo in the cat.
    Chesselet MF; Cheramy A; Reisine TD; Lubetzki C; Glowinski J; Fournie-Zaluski MC; Roques B
    Life Sci; 1982 Nov 15-22; 31(20-21):2291-4. PubMed ID: 6298522
    [No Abstract]   [Full Text] [Related]  

  • 39. Prenatal and neonatal exposure to bisphenol-A affects the morphine-induced rewarding effect and hyperlocomotion in mice.
    Mizuo K; Narita M; Miyagawa K; Narita M; Okuno E; Suzuki T
    Neurosci Lett; 2004 Feb; 356(2):95-8. PubMed ID: 14746872
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neurochemical bases for narcotic tolerance and dependence.
    Takemori AE
    Biochem Pharmacol; 1975 Dec; 24(23):2121-6. PubMed ID: 813643
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.